Treatment

Intravenous immunoglobulin (IVIG), 10% solution for infusion clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)
This study looks into a new way to deliver medicine for ALS. It uses a special helmet with sound waves to help a drug called IVIG reach the brain better. The main aim is to see if it's safe to do this.
For: Amyotrophic Lateral Sclerosis · ALS
Canada